Emergent BioSolutions Inc. (EBS) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Services	1,792.7	1,555.4	1,106.0	782.4	560.9	488.8	489.3	404.5
Services growth	15.3%	40.6%	41.4%	39.5%	14.8%	-0.1%	21.0%	29.3%
Total revenues	1,792.7	1,555.4	1,106.0	782.4	560.9	488.8	489.3	404.5
Total revenues growth	15.3%	40.6%	41.4%	39.5%	14.8%	-0.1%	21.0%	29.3%
Operating expenses:
Cost of goods and services sold				322.3	187.7	126.3
Research and development	234.0	234.5	226.2	142.8	97.4	106.9	119.2	104.7
Selling, general and administrative	348.4	303.3	273.5	202.5	142.9	143.1	121.1	108.6
Amortization of intangible assets	58.5	59.8	58.7	25.0	8.6	7.0
Loss from operations	352.6	433.8	114.1	89.8	124.3	105.5	141.5	89.2
Operating margin	19.7%	27.9%	10.3%	11.5%	22.2%	21.6%	28.9%	22.1%

Other income (expense):
Interest expense	-34.5	-31.3	-38.4	-9.9	-6.6	-7.6	-6.5	-8.2
Other, net	-3.7	4.7	1.7	1.6	0.9	1.3	0.2	2.9
Total other income (expense), net	-38.2	-26.6	-36.7	-8.3	-5.7	-6.3	-5.8	-5.0
Income tax provision (benefit)	83.5	102.1	22.9	18.8	36.0	36.7	44.3	29.9
Net loss	230.9	305.1	54.5	62.7	82.6	51.8	62.9	36.7

Net loss per common share
Basic (in dollars per share)	$4.32	$5.79	$1.06	$1.25	$1.98	$1.29	$1.63	$0.98
Diluted (in dollars per share)	$4.27	$5.67	$1.04	$1.22	$1.71	$1.13	$1.41	$0.88

Weighted average shares outstanding
Basic (in shares)	53.5	52.7	51.5	50.1	41.8	40.2	38.6	37.3
Diluted (in shares)	54.1	53.8	52.4	51.4	50.3	49.3	47.3	45.8